Home SportsEconomyBusinessTechnologyEntertainmentHeightsEnergy
Insider Q&A: Narcan exec talks merits of spray for overdoses
Published in 2-1-2018
    578 Visits
NEW YORK (AP) Dr. Roger Crystal's company was struggling to find new uses for an old drug that reverses overdoses. Then the opioid epidemic hit. Naloxone had first gone on sale in 1971 but was injected with a syringe. Crystal and his colleagues came up with a naloxone nasal spray, intended to be more appealing than prefilled injectors or the other naloxone alternatives. Crystal's Opiant Pharmaceuticals Inc. partnered with Adapt Pharma to market the spray version. Adapt revived the brand name Narcan, which had fallen out of use after naloxone went generic. The spray went on sale in the U.S. last year. It costs $125 for a twin-pack; police and other groups pay $75. Crystal talked to The Associated Press about the development of Narcan.